Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a Randomized Controlled Trial

Andrea Carralero‐Martínez, Miguel Ángel Muñoz Pérez, R. Pané-Alemany, Laia Blanco‐Ratto, S. Kauffmann, Inés Ramírez‐García
In: Research Square · 2021 · doi:10.21203/rs.3.rs-194630/v1 · W4248103800
preprint OA: green CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

This randomized controlled trial protocol aims to evaluate capacitive resistive monopolar radiofrequency as an adjunct to physiotherapy for reducing pain and improving quality of life in patients with chronic pelvic pain syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 ⓘ

This paper describes a triple-blind randomized controlled trial protocol testing whether capacitive resistive monopolar radiofrequency (CRMRF) at 448 KHz, used as an adjunct to standard physiotherapeutic techniques and pain education, improves outcomes for patients with chronic pelvic pain syndrome (CPPS). Eighty women and men with CPPS are randomized to an activated versus deactivated CRMRF group, with assessments of pain intensity (VAS), quality of life (SF-12), kinesiophobia (TSK-11), and catastrophism (PCS) at baseline, mid-treatment, and at treatment completion over 10 consecutive weeks. The key limitation is that this is a protocol for a preprint under review, so efficacy results are not yet reported. Relevance to endometriosis: eligibility explicitly includes CPPS etiologies such as endometriosis and adenomyosis, though the paper’s main focus is the CRMRF trial protocol for CPPS across multiple causes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK